MVM
SNTI icon

Menlo Ventures Management’s Senti Biosciences Holdings SNTI Stock Holding History

Menlo Ventures Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.3K Hold
35,737
– – 0.01% 3
2026
Q1 		$29K Buy
+35,737
New +$34.6K 0.01% 3

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Menlo Ventures Management's SNTI Position: Q2 2026 in Review

Menlo Ventures Management held its Senti Biosciences Holdings (SNTI) position steady in Q2 2026 at 35,737 shares worth $39.3K. The position accounts for 0.01% of the portfolio, ranked #3.

Menlo Ventures Management first reported a position in SNTI in Q1 2026 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • Menlo Ventures Management held 35,737 shares of Senti Biosciences Holdings worth $39.3K as of Q2 2026.
  • Menlo Ventures Management left its Senti Biosciences Holdings share count unchanged in Q2 2026.
  • Senti Biosciences Holdings made up 0.01% of Menlo Ventures Management's portfolio in Q2 2026, its #3 holding.
  • Menlo Ventures Management first reported a position in Senti Biosciences Holdings in Q1 2026 and has held it in 2 quarters since.
  • 19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Menlo Ventures Management's 13F filing for Q2 2026, filed 10 Aug 2026.